Global /India /Healthcare /Medical Care Facilities /LALPATHLAB

Dr. Lal PathLabs Ltd.

LALPATHLAB

• NSE: LALPATHLAB • Delayed

1,367.20INR -2.2%

14.33 USD

As of 6 June 2026, Dr. Lal PathLabs Ltd. has a market cap of $2.44B USD, ranking #6205 globally and #321 in India. It ranks #494 in the Healthcare sector, and #53 in the Medical Care Facilities industry.

Global Rank

6205

Country Rank

321

Sector Rank

494

Industry Rank

Key Stats

Market Cap

$2.44BUSD

233.58B INR

Enterprise Value

$2.33BUSD

222.47B INR

Revenue (TTM)

$278.1MUSD

26.63B INR

EBITDA (TTM)

$74.97MUSD

7.15B INR

Net Income (TTM)

$55.18MUSD

5.28B INR

EBITDA Margin

27%

Profit Margin

20%

PE Ratio

44.2

Forward PE

40.5

PS Ratio

8.8

PB Ratio

9.6

EV/EBITDA

29.6

Company Profile

Country (HQ)

India

Sector

Healthcare

Industry

Medical Care Facilities

CEO

Shankha Banerjee open_in_new

Employees

4,980

Founded

1949

Website

lalpathlabs.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-2.2%	-2.7%	5.5%	-0.2%	-9.6%	-5.7%	-0.6%	43%	-2.2%

News

Markets

Exchange	Ticker	Price	Quotes
National Stock Exchange of India (NSE) MIC: XNSE PRIMARY	LALPATHLAB Dr. Lal PathLabs Ltd ISIN: INE600L01024 Shares Out.: Shares Outstanding: 166.822M¹ Shares Float: 75.826M² TV: TradingView: NSE: LALPATHLAB SA: Stock Analysis: NSE: LALPATHLAB YF: Yahoo Finance: LALPATHLAB.NS GF: Google Finance: NSE: LALPATHLAB BA: Barron's: LALPATHLAB MS: Morningstar: XNSE: LALPATHLAB	1,367.20 INR	TV: TradingView: NSE: LALPATHLAB SA: Stock Analysis: NSE: LALPATHLAB YF: Yahoo Finance: LALPATHLAB.NS GF: Google Finance: NSE: LALPATHLAB BA: Barron's: LALPATHLAB MS: Morningstar: XNSE: LALPATHLAB
Bombay Stock Exchange (BSE / BOM) MIC: XBOM	539524 (LALPATHLAB) Dr. Lal PathLabs Ltd ISIN: INE600L01024 TV: TradingView: BSE: LALPATHLAB SA: Stock Analysis: BOM: 539524 YF: Yahoo Finance: 539524.BO GF: Google Finance: BOM: 539524 BA: Barron's: 539524 MS: Morningstar: XBOM: 539524	1,397.50 INR	TV: TradingView: BSE: LALPATHLAB SA: Stock Analysis: BOM: 539524 YF: Yahoo Finance: 539524.BO GF: Google Finance: BOM: 539524 BA: Barron's: 539524 MS: Morningstar: XBOM: 539524

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Dr. Lal PathLabs Ltd.

Dr. Lal PathLabs Limited operates laboratories for carrying out pathological investigations in India and internationally. The company provides pathological investigations of various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. It also offers phlebotomist training programs. The company was founded in 1949 and is based in Gurugram, India.

Similar Companies

Industry: Medical Care Facilities (India)

Name	Market Cap (USD) diff.	PE	Country
Apollo Hospitals Enterprise Ltd. NSE: APOLLOHOSP	$11.47B 1.1T INR 370%	60.9	India
Max Healthcare Institute Ltd. NSE: MAXHEALTH	$10.22B 978.68B INR 319%	69.0	India
Fortis Healthcare Ltd. NSE: FORTIS	$7.37B 706.04B INR 202%	73.6	India
Narayana Hrudayalaya Ltd. NSE: NH	$3.76B 359.57B INR 54%	46.2	India
Global Health Ltd. NSE: MEDANTA	$3.14B 300.37B INR 29%	58.5	India
Krishna Institute of Medical Sciences Ltd. NSE: KIMS	$2.78B 266.19B INR 14%	88.6	India

Industry: Medical Care Facilities (Global)

Name	Market Cap (USD) diff.	PE	Country
International Holding Company PJSC ADX: IHC	$232.18B 852.82B AED 9K%	44.1	United Arab Emirates
HCA Healthcare, Inc. NYSE: HCA	$96.73B 4K%	14.9	United States
Fresenius SE & Co. KGaA XETRA: FRE	$26.68B 22.97B EUR 994%	15.0	Germany
Koninklijke Philips N.V. AMS: PHIA	$25.58B 22.02B EUR 949%	24.9	Netherlands
Dr. Sulaiman Al Habib Medical Services Group Co. TADAWUL: 4013	$22.48B 84.42B SAR 822%	35.2	Saudi Arabia
Labcorp Holdings Inc. NYSE: LH	$21.13B 766%	24.6	United States

chevron_leftBack